Claire M. Rice
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.
Journal: Health technology assessment (Winchester, England)
Published: August 11, 2026
Hyperammonaemic encephalopathy presenting as a stroke mimic with normal liver function tests.
Journal: BMJ case reports
Published: July 10, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.
Journal: Health technology assessment (Winchester, England)
Published: June 29, 2026
Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 31, 2026
The 2024 McDonald criteria for the diagnosis of multiple sclerosis: implications for clinical practice.
Journal: Practical neurology
Published: April 28, 2026
Primary central nervous system vasculitis: an update.
Journal: Journal of neurology
Published: February 09, 2026
Profiling peripheral blood oxidative stress in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: October 30, 2025
Cerebral venous sinus thrombosis complicating IgG4-related hypertrophic pachymeningitis.
Journal: Practical neurology
Published: September 05, 2025
Trajectories of change in experiences of multiple sclerosis: insights from an online group psychological intervention.
Journal: Disability and rehabilitation
Published: August 25, 2025
Defining Activity-Based Subgroups in Multiple Sclerosis: A Review and Framework Proposal.
Journal: European journal of neurology
Published: August 01, 2025
Acute retinal necrosis associated with dimethyl fumarate.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 05, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: March 23, 2025
Last Updated: 09/26/2026